Namba, Shinichi Saito, Yuki Kogure, Yasunori Masuda, Tatsuo Bondy, Melissa L Gharahkhani, Puya Gockel, Ines Heider, Dominik Hillmer, Axel Jankowski, Janusz
...
Published in
Cancer research
Aggregation of genome-wide common risk variants, such as polygenic risk score (PRS), can measure genetic susceptibility to cancer. A better understanding of how common germline variants associate with somatic alterations and clinical features could facilitate personalized cancer prevention and early detection. We constructed PRSs from 14 genome-wid...
Kim, Kee-Beom Kim, Dong-Wook Kim, Youngchul Tang, Jun Kirk, Nicole Gan, Yongyu Kim, Bongjun Fang, Bingliang Park, Jae-Ll Zheng, Yi
...
Published in
Cancer research
WNT signaling represents an attractive target for cancer therapy due to its widespread oncogenic role. However, the molecular players involved in WNT signaling and the impact of their perturbation remain unknown for numerous recalcitrant cancers. Here, we characterize WNT pathway activity in small cell lung cancer (SCLC) and determine the functiona...
Halperin, Coral Hey, Joschka Weichenhan, Dieter Stein, Yaniv Mayer, Shimrit Lutsik, Pavlo Plass, Christoph Scherz-Shouval, Ruth
Published in
Cancer research
Cancer cells recruit and rewire normal fibroblasts in their microenvironment to become protumorigenic cancer-associated fibroblasts (CAF). These CAFs are genomically stable, yet their transcriptional programs are distinct from those of their normal counterparts. Transcriptional regulation plays a major role in this reprogramming, but the extent to ...
Yan, Qian Jiang, Lingxi Liu, Ming Yu, Dandan Zhang, Yu Li, Yan Fang, Shuo Li, Yan Zhu, Ying-Hui Yuan, Yunfei
...
Published in
Cancer research
Zerhouni, Marwa Piskounova, Elena
Published in
Cancer research
The role of exercise in cancer progression is an emerging field of research, with intriguing evidence for physical activity playing an inhibitory role in cancer onset. In their recent publication, Sheinboim and colleagues demonstrate the impact of physical exercise on melanoma primary tumor growth and metastasis. They establish that physical exerci...
Goodwin, Craig M Waters, Andrew M Klomp, Jennifer E Javaid, Sehrish Bryant, Kirsten L Stalnecker, Clint A Drizyte-Miller, Kristina Papke, Bjoern Yang, Runying Amparo, Amber M
...
Published in
Cancer research
Mutational loss of CDKN2A (encoding p16INK4A) tumor suppressor function is a key genetic step that complements activation of KRAS in promoting the development and malignant growth of pancreatic ductal adenocarcinoma (PDAC). However, pharmacologic restoration of p16INK4A function with inhibitors of CDK4 and CDK6 (CDK4/6) has shown limited clinical e...
Zhu, Xingxin Song, Guangyuan Zhang, Shiyu Chen, Jun Hu, Xiaoyi Zhu, Hai Jia, Xing Li, Zequn Song, Wenfeng Chen, Jian
...
Published in
Cancer research
Liver cancer is characterized by aggressive growth and high mortality. Asialoglycoprotein receptor 1 (ASGR1), which is expressed almost exclusively in liver cells, is reduced in liver cancer. However, the specific mechanism of ASGR1 function in liver cancer has not been fully elucidated. On the basis of database screening, we identified ASGR1 as a ...
Scharpf, Robert B Balan, Archana Ricciuti, Biagio Fiksel, Jacob Cherry, Christopher Wang, Chenguang Lenoue-Newton, Michele L Rizvi, Hira A White, James R Baras, Alexander S
...
Published in
Cancer research
The RAS family of small GTPases represents the most commonly activated oncogenes in human cancers. To better understand the prevalence of somatic RAS mutations and the compendium of genes that are coaltered in RAS-mutant tumors, we analyzed targeted next-generation sequencing data of 607,863 mutations from 66,372 tumors in 51 cancer types in the AA...
Guo, Qianying Wang, Hao Duan, Jiahao Luo, Wenwu Zhao, Rongrong Shen, Yuting Wang, Bijun Tao, Siqi Sun, Yi Ye, Qian
...
Published in
Cancer research
Resistance to chemotherapy remains a major obstacle to the successful treatment of breast cancer. More than 80% of patients who receive neoadjuvant chemotherapy (NAC) do not achieve a pathologic complete response. In this study, we report a novel p62 mRNA isoform with a short 3'-UTR (untranslated region; p62-SU, 662-nt) that is associated with chem...
Perrone, Milena Chiodoni, Claudia Lecchi, Mara Botti, Laura Bassani, Barbara Piva, Annamaria Jachetti, Elena Milani, Matteo Lecis, Daniele Tagliabue, Elda
...
Published in
Cancer research
Cancer is a systemic disease able to reprogram the bone marrow (BM) niche towards a pro-tumorigenic state. The impact of cancer on specific BM subpopulations can qualitatively differ according the signals released by the tumor, which can vary based on the tissue of origin. Using a spontaneous model of mammary carcinoma, we identified BM mesenchymal...